SAN FRANCISCO—Continuing to broadening the company's scope into the life sciences market, semiconductor equipment vendor Brooks Automation Inc. said Monday (July 25) it acquired life sciences technology vendor Nexus Biosystems Inc. in a cash deal worth $79 million.
Nexus represents an important next step in our strategy to build a meaningful position in a rapid, secular growth market," said Steve Schwartz, president and CEO of Brooks, in a statement. "Together with our other recent acquisition, RTS Life Sciences, and our core technical competencies at Brooks, we plan to build Brooks Life Science Systems into the market and innovation leader in bio-banking and compound sample management."
Brooks announced in April that it completed the acquisition of RTS, a U.K.-based provider of automation solutions to life sciences markets.
"We will be making meaningful development expenditures in next generation automated sample management products over the next 12 to 15 months that will moderate operate margins from the attractive levels we expect to see thereafter," said Martin Headley, Brooks executive vice president and chief financial officer.
In addition to the $79 million purchase price for Nexus, Brooks said it paid an additional $6.7 million for the value of the unrestricted cash held by Nexus at closing. Nexus (Poway, Calif.) generated revenue of $36 million for the 12 months ended June 30, Brooks (Chelmsford, Mass.) said.